National Consensus on Diagnosis and Management Guidelines for Primary Immunodeficiency

National Consensus on Diagnosis and Management Guidelines for Primary Immunodeficiency

Archive of SID Immunology and Genetics Journal Received: 19 January 2019 Accepted: 24 February 2019 Reveiw Article Published online: 22 March 2019 Doi: 10.22034/igj.2019.172502.1009 National Consensus on Diagnosis and Management Guidelines for Primary Immunodeficiency 1 2 3 4 5 Hassan Abolhassani , , , Marzieh Tavakol , Zahra Chavoshzadeh , Seyed Alire- 6 7 1 3 8 za Mahdaviani , Tooba Momen , RezaYazdani , , Gholamreza Azizi , Masoud 9 10 11 30 Movahedi , Amir Ali Hamidieh , Nasrin Behniafard , , Mohammamd Naba- 12 12 12 12 vi , Saba Arshi , Mohammad Hassan Bemanian , Morteza Fallahpour , 12 13 14 16 Sima Shokri , Rasol Molatefi , Roya Sherkat , Afshin Shirkani , Reza 17 17 18 18 Amin ,Soheila Aleyasin , Reza Faridhosseini , Farahzad Jabbari-Azad , 19 20 21 22 Iraj Mohammadzadeh , Javad Ghaffari , Alireza Shafiei , Arash Kalantari , 15 15 5 Mahboubeh Mansouri , Mehrnaz Mesdaghi , Delara Babaie , Hamid Ah- 18 18 23 anchian , Maryam Khoshkhui , Habib Soheili , Mohammad Hossein Esla- 24 25 19 26 mian , Taher Cheraghi , Abbas Dabbaghzadeh , Mahmoud Tavassoli , 27 28 17 Rasoul Nasiri Kalmarzi , Seyed Hamidreza Mortazavi , Sara Kashef , Hos- 17 29 30 21 sein Esmaeilzadeh , Javad Tafaroji , Abbas Khalili , Fariborz Zandieh , 31 44 17 Mahnaz Sadeghi-Shabestari , Sepideh Darougar , Fatemeh Behmanesh , 17 18 32 Hedayat Akbari , Mohammadreza Zandkarimi , Farhad Abolnezhadian , 32 17 33 Abbas Fayezi , Mojgan Moghtaderi , Akefeh Ahmadiafshar , Behzad Shake- 26 34 35 24 rian , Vahid Sajedi , Behrang Taghvaei , Mojgan Safari , Marzieh Heidar- 36 25 37 38 zadeh , Babak Ghalehbaghi , Seyed Mohammad Fathi , Behzad Darabi , 16 39 12 Saeed Bazregari , Nasrin Bazargan , Morteza Fallahpour , Alireza Kha- 1 12 6 yatzadeh , Naser Javahertrash , Bahram Bashardoust , Mohammadali Zama- 40 41 9 16 ni , Azam Mohsenzadeh , Sarehsadat Ebrahimi , Samin Sharafian , Ahmad 9 9 9 9 Vosughimotlagh , Mitra Tafakoridelbari , Maziar Rahimi , Parisa Ashournia , 9 43 42 Anahita Razaghian , Fatemeh Aghaeimeybodi , Setareh Mamishi , Nima 1,3 1,3 1,3 Parvaneh , Nima Rezaei , Asghar Aghamohammadi www.SID.ir Archive of SID 1. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran, and the University of Medical Science, Tehran, Iran 2. Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institute at Karolinska University Hospital Hud- dinge, Stockholm, Sweden 3. Iranian Primary Immunodeficiencies Network (IPIN), Tehran University of Medical Science, Tehran, Iran 4. Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran 5. Pediatric Infections Research Center, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran 6. Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran 7. Department of Allergy and Clinical Immunology, Child Growth and Development Research Center, Research Institute for Primordi- al Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran 8. Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran 9. Division of Allergy and Clinical Immunology, Department of Pediatrics, Pediatrics Center of Excellence, Children’s Medical Center, Tehran, University of Medical Sciences, Tehran, Iran 10. Hematology, Oncology and Stem Cell Transplantation Research Centre, Tehran University of Medical Sciences, Tehran, Iran 11. Department of Allergy and Clinical Immunology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran 12. Department of Allergy and Clinical Immunology, Rasool e Akram Hospital, Iran University of Medical Sciences, Tehran, Iran 13. Department of Pediatrics, Bo-Ali children’s Hospital of Ardabil University of Medical Sciences, Ardabil, Iran 14. Acquired Immunodeficiency Research Center, lsfahan University of Medical Sciences, Isfahan, lran 15. Immunology and Allergy Department, Mofid Children’s Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran 16. Allergy and Clinical Immunology Department, Bushehr University of Medical Science, School of Medicine, Bushehr, Iran 17. Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran 18. Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran 19. Noncommunicable Pediatric Diseases Research Center, Amirkola Hospital, Babol University of Medical Sciences, Babol, Iran 20. Department of Pediatrics, Mazandaran University of Medical Sciences, Sari, Iran 21. Department of Immunology, Bahrami Hospital, Tehran University of Medical Sciences, Tehran, Iran 22. Department of Immunology and Allergy, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran 23. Department of Pediatrics, School of Medicine, Arak University of Medical Sciences, Arak, Iran 24. Department of Pediatrics, Hamadan University of Medical Sciences, Hamadan, Iran 25. Department of Pediatrics, 17th Shahrivar Children’s Hospital, Guilan University of Medical Sciences, Rasht, Iran 26. Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran 27. Cellular & Molecular Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran 28. Department of Pediatrics, Kermanshah University of Medical Sciences, Kermanshah, Iran 29. Department of Pediatrics, Qom University of Medical Sciences, Qom, Iran 30. Department of Pediatrics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran 31. Department of Immunology and Allergy, Tabriz University of Medical Sciences, Tabriz, Iran 32. Department of Immunology and Allergy, Ahvaz University of Medical Sciences, Ahvaz, Iran 33. Mousavi Hospital, Zanjan University of Meical Sciences, Zanjan, Iran 34. Department of Immunology and Allergy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran 35. Department of Immunology and Allergy, Semnan University of Medical Sciences, Semnan, Iran 36. Department of Immunology and Allergy, Kashan University of Medical Sciences, Kashan, Iran 37. Department of Immunology and Allergy, Qazvin University of Medical Sciences, Qazvin, Iran 38. Department of Immunology and Allergy, Ilam University of Medical Sciences, Ilam, Iran 39. Department of Immunology and Allergy, Kerman University of Medical Sciences, Kerman, Iran 40. Department of Immunology and Allergy, Shahrekord University of Medical Sciences, Shahrekord , Iran 41. Department of Pediatrics, Lorestan University of Medical Sciences, Khorramabad, Iran 42. Pediatric Infectious Diseases Research Center, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Med- ical Science, Tehran, Iran www.SID.ir National Consensus for PID Abolhassani et al. Archive of SID Abstract Primary immunodeficiency (PID) is a group of more than 400 distinct genetic disorders affecting both children and adults. As signs and symptoms of PID are usually heterogeneous and unspecific, diagnosis and follow-up of these patients can be challenging based on the available human resources and laboratory facilities. In order to reach a distinct national protocol and due to little evidence to guide appropriate or univer- sal guidelines to improve the current status of management of the disease, the Iranian PID network designed a consensus appropriate for regional resources. This review summarizes this PID guideline based on the importance of different clinical complications and the level of medical authority visiting those at the first line. Moreover, for each complication, appropriate interventions for improving ap- proach are mentioned. Keywords Primary immunodeficiency, Symptoms, Management, Consensus, Guideline. * Corresponding author: Asghar Aghamohammadi E-mail: [email protected] 1. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran, and the University of Medical Science, Tehran, Iran 2. Iranian Primary Immunodeficiencies Network (IPIN), Tehran University of Medical Science, Tehran, Iran Introduction mainly pediatricians and infectious disease Primary immunodeficiency (PID), as a heteroge- specialists) and clinical immunologists (third neous group of inherited disorders, is character- line referrals). In the third level of approach ized by higher incidence of frequent infections, regarding clinical diagnosis, since 2011 on- immune dysregulations and cancers, as well as wards, European Society for Immunodeficien- non-immune complications in syndromic forms cies has updated the clinical diagnostic criteria of PID. The prevalence of these disorders should regarding PID (https://esid.org/Working-Par- not be thought of as being rare (1:600), where the ties/Registry-Working-Party/Diagnosis-crite- onset (early or late) and clinical manifestations ria). Further, for molecular diagnosis and defi- (distinct phenotypes) of the disease have hetero- nite classification of PIDs, International Union geneous presentations. This variability in clinical of Immunological Societies (IUIS) has catego- phenotype and immunologic profile of disease rized these diseases since 1999 (1). may lead to delayed PID diagnosis. However, the task of family physicians, as well Heterogeneity in PID refers to variability in as first and second line physicians toward diag- genetic defects underlying the diverse clinical nosis of PID and completing the cycle is rather symptoms described in this group of patients. elementary. Here,

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    15 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us